Published in Blood Weekly, November 10th, 1997
Developed at the Norwegian Radium Hospital in Oslo, Norway, the new procedure is used to check for signs of remission after treatment of the disease or to identify patients who have a high risk of developing secondary cancers.
Professor Oeystein Fodstad said the method could save some patients from the unnecessary side-effects of toxic therapy after surgery, while ensuring that those in need of follow up toxic treatment received it as soon as possible.
"It may mean that we can...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.